InvestorsHub Logo
Followers 14
Posts 306
Boards Moderated 0
Alias Born 01/17/2021

Re: DewDiligence post# 1074

Saturday, 04/02/2022 5:14:43 PM

Saturday, April 02, 2022 5:14:43 PM

Post# of 1162
Certainly BMY never would've parted with China franchise.

[BMY] may be eligible to receive regulatory and sales milestone payments of up to $147.5 million, as well as tiered double-digit royalties on the sale of mavacamten in the [China] territories outlined as part of the collaboration.



Lian is happy to let BMY do all the heavy lifting. Go BMY!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News